Altheus Therapeutics announces completion of Zoenasa phase I trial for ulcerative colitis
Links shared publicly online about this topic.
- 599total visits
Altheus Therapeutics announces completion of Zoenasa phase I trial for ulcerative colitis
Altheus Therapeutics, announced that it has completed a two dose, double-blind, active-controlled Phase I clinical trial of the safety and tolerability of Zoenasa Rectal Suspension in adult patients with left-sided, or distal, ulcerative colitis.
View full resource at news-medical.net
Tags: Rectum, IBD, Ulcerative Colitis, Clinical Trial, Safety, Ulcer
Most Recently Shared on January 7, 2011 at 4:57 am By:
Altheus Therapeutics announces completion of Zoenasa phase I trial for ulcerative colitis: Altheus Therapeutics,... http://bit.ly/gAqdLS
Advertisement
